EVOL-SI Joint

Cutting Edge Spine Announces FDA 510(K) Clearance of its EVOL-SI Joint Fusion System; Bringing Novel Super Hydrophilic Nano-technology to the Sacral-iliac Fixation Market

WAXHAW, N.C. (PRWEB) AUGUST 20, 2019 Cutting Edge Spine, a leader in the organic development and commercialization of bioactive technologies for the…